Cargando…

Responses to the First Radioactive Iodine Treatment After Targeted Therapy for Aggressive Papillary Thyroid Cancers

Introduction: Tall cell variant (TCV) and columnar cell variant (CCV) are aggressive variants of papillary thyroid cancer (PTC) and they are overrepresented in radioactive iodine (RAI) refractory cases. Studies have reported using BRAF and/or MEK inhibitors to restore iodine avidity in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soe, Myat Han, Chiang, Janet, Kang, Hyunseok, Liu, Chienying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090130/ http://dx.doi.org/10.1210/jendso/bvab048.1836

Ejemplares similares

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

SAT569 Papillary Thyroid Carcinoma With Renal Metastasis Treated With Radioactive Iodine: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023)

SAT559 Challenges Involved in Managing a Paraplegic Patient with Metastatic Papillary Thyroid Cancer Requiring Radioactive Iodine Therapy
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

ODP532 Fractionated Radioactive Iodine Therapy in Management of Differentiated Thyroid Cancer
por: Khan, Adeel Ahmad, et al.
Publicado: (2022)

SAT558 Papillary Thyroid Carcinoma With Anaplastic Transformation in a Filipino Male Treated With Radioactive Iodine and Radiotherapy: A Case Report
por: Apa-Ap, Archimedes Almasol, et al.
Publicado: (2023)

MON-447 Schwannoma Masquerading as Metastatic Papillary Thyroid Carcinoma in a Cervical Lymph Node
por: Kim, Stephanie, et al.
Publicado: (2020)

MON-494 Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to the Treatment: Total Thyroidectomy Versus Total Thyroidectomy with Radioactive Iodine Remnant Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

MON-591 Thyroid Function and Autoimmunity Status after One and Three Months of Radioactive Iodine Therapy for Thyrotoxicosis
por: Irigoitia, Bruna, et al.
Publicado: (2019)

SAT-601 Navigating The Storm: A Case of Thyroid Storm and Recurrent Grave's Disease after Radioactive Iodine Therapy
por: Parikh, Foram, et al.
Publicado: (2019)

SAT448 Effects Of Radioactive Iodine Therapy Of Compensated Autonomous Thyroid Nodule After Pharmacological Suppression Of Tsh Secretion
por: Skoczylas, Aleksander, et al.
Publicado: (2023)

ODP480 Failure to achieve remission post Radioactive iodine therapy
por: Paliou, Maria, et al.
Publicado: (2022)

FRI494 Ischemic Stroke After Radioactive Iodine Therapy In Graves Disease
por: Rave, Talia, et al.
Publicado: (2023)

PSAT264 Effectiveness of Thyroid Gland Size Determination by Ultrasonography versus Manual Palpation in Success of Radioactive Iodine Therapy for Graves’ Disease
por: Choksakunwong, Sawaraj, et al.
Publicado: (2022)

MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)
por: Leboulleux, Sophie, et al.
Publicado: (2021)

SAT530 Use of Tamoxifen and Cabergoline to Suppress Breast Tissue Uptake of Radioactive Iodine Among Differentiated Thyroid Cancer Patients
por: Mohamed, Abubakr H B, et al.
Publicado: (2023)

Treatment of Graves’ Disease With a Combination of Low Iodine Diet and Potassium Iodide Plus Radioactive Iodine Treatment
por: Ebrahim, Ismail, et al.
Publicado: (2021)

A Case for Lithium Pretreatment Prior to Radioactive Iodine Ablation in Grave’s Disease
por: Thakkar, Aditi, et al.
Publicado: (2021)

FRI542 Long-term Metabolic Outcomes In Graves’ Disease: Is There A Difference Between Oral Anti-thyroid Medications And Radioactive Iodine Treatment?
por: Shemesh, Elad, et al.
Publicado: (2023)

Columnar Cell Variant of Papillary Thyroid Carcinoma: Ultrasonographic and Clinical Differentiation between the Indolent and Aggressive Types
por: Cho, Jooyeon, et al.
Publicado: (2018)

SAT543 A Case of Non-iodine-Avid Papillary Thyroid Cancer With a Rare Distant Metastasis to the Pancreas
por: Huliganga Alcain, Alistair Marie, et al.
Publicado: (2023)

MON-590 Outcomes Following Radioactive Iodine Therapy (RAI) in Hyperthyroid Patients with Grave’s Disease and Toxic Nodular Disease
por: Aljenaee, Khaled, et al.
Publicado: (2019)

A Case of Diffuse Sclerosing Variant of Papillary Thyroid Cancer: An Aggressive Variant Presenting With Recurrent Locoregional Nodal Disease
por: Cruz, Yaniris García, et al.
Publicado: (2021)

Thyroid Hormone Resistance With Concurrent Papillary Thyroid Cancer
por: Pahwa, Dhivya, et al.
Publicado: (2021)

Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
por: Creach, Kimberly M., et al.
Publicado: (2012)

SAT-427 Quality of Life Following Treatment for Graves’ Disease: A Comparison of Radioactive Iodine Ablation and Surgery
por: Rowe, Christopher W, et al.
Publicado: (2020)

SAT469 Risk Factors for Relapse in Graves’ Disease and the Clinical Outcomes of Radioactive Iodine Treatment in Relapsed Cases
por: WingChing, Li, et al.
Publicado: (2023)

LBODP096 High Failure Rate Of Radioactive Iodine-131 (Rai) Therapy For The Treatment Of Grave's Disease And Toxic Multinodular Goiter In An Urban Municipal Hospital Clinic
por: Handoo, Maryam Manzoor, et al.
Publicado: (2022)

Hashimoto’s thyroiditis in papillary thyroid carcinoma: a 22-year study
por: Hanege, Fatih Mehmet, et al.
Publicado: (2021)

LBSAT291 Familial Papillary Thyroid Carcinoma
por: Arora, Gunjan
Publicado: (2022)

Birth Rates After Radioactive Iodine Treatment for Well Differentiated Cancer in Female Patients With Reproductive Potentials: A Meta- Analysis
por: Cheng, Ce, et al.
Publicado: (2021)

A Subtype of Papillary Thyroid Carcinoma Bone Metastasis With Excellent Response to RAI-Therapy
por: Vodopivec, Danica M, et al.
Publicado: (2021)

Incidental Diffuse Sclerosing Variant Papillary Thyroid Cancer in Grave’s Disease
por: Canales, Nicolle, et al.
Publicado: (2021)

SUN-624 Occurrence Of Papillary Thyroid Cancer During Treatment Of Thyroid Dysfunction
por: Ercan, Oya, et al.
Publicado: (2019)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

SUN-601 Papillary Thyroid-like Carcinoma Of The Kidney
por: Shashpal, FNU, et al.
Publicado: (2019)

MON-455 Papillary Thyroid Carcinoma in the Thyroglossal Duct
por: Franco, Katty Manrique, et al.
Publicado: (2020)

Papillary Thyroid Carcinoma With Axillary Lymph Node Metastasis
por: Khan, Mehvish, et al.
Publicado: (2021)

Clavicular Metastasis as an Initial Presentation of Papillary Thyroid Cancer
por: Fung, Russell K, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r3l30qdgr1suc5mrogjnkmue9o